| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |